DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

UCAL LIMITED — Action(s) initiated or orders passed

NSE 1 hr ago·25 Sept 2026, 11:30 am

Ucal

UCAL Limited has informed the stock exchanges that certain regulatory actions have been initiated or orders passed against the company. This development typically refers to compliance issues, penalties, or regulatory scrutiny that the company is currently addressing with the relevant authorities.

For investors, this news is a signal to review the company's filings and understand the nature of the regulatory matter. It may indicate operational challenges or compliance gaps that could impact the company's reputation or financial performance in the short term.

Investors should watch for the company's official clarification on the exchange and any subsequent updates regarding the resolution of these actions. Monitoring the company's response will be key to assessing the potential impact on its business operations.